MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory ...
YD Bio Limited ('YD Bio Ltd” or the 'Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer ...
NEW YORK--(BUSINESS WIRE)--Peak Bio Co., Ltd. (“Peak Bio”), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory ...
GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions Ltd (“Bio-Thera”) announced today that it has reached a licensing agreement with Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter ...
Bio-Gene Technology Ltd. ( (AU:BGT)) just unveiled an announcement. Bio-Gene Technology reported strong operational momentum in the December 2025 quarter as it advanced both its Flavocide and Qcide ...
On July 16, 2025, Bio-Thera Solutions, Ltd. (“Bio-Thera”) announced that the U.S. Food and Drug Administration (“FDA”) had accepted its Biologics License Application (“BLA”) for its golimumab ...
Karo Bio AB (publ) and Alkem Laboratories Ltd have entered into a collaboration and license agreement regarding eprotirome, currently in late-stage clinical testing for dyslipidemia. Karo Bio will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results